Last Updated: June 22, 2026

BACTERIOSTATIC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Bacteriostatic, and when can generic versions of Bacteriostatic launch?

Bacteriostatic is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, and Hospira. and is included in six NDAs.

The generic ingredient in BACTERIOSTATIC is sterile water for injection. There are one thousand and seventy-two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the sterile water for injection profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for BACTERIOSTATIC?
  • What are the global sales for BACTERIOSTATIC?
  • What is Average Wholesale Price for BACTERIOSTATIC?
Summary for BACTERIOSTATIC
US Patents:0
Applicants:3
NDAs:6
DailyMed Link:BACTERIOSTATIC at DailyMed

US Patents and Regulatory Information for BACTERIOSTATIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 088909-002 May 15, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 018800-003 Oct 29, 1982 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 088911-001 Feb 7, 1985 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Abraxis Pharm BACTERIOSTATIC WATER FOR INJECTION IN PLASTIC CONTAINER sterile water for injection LIQUID;N/A 089099-001 Dec 29, 1987 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Abraxis Pharm BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 088909-001 Feb 7, 1985 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.